cerca CERCA
Mercoledì 26 Gennaio 2022
Aggiornato: 05:21
Temi caldi

testing

Agendia, HiSS Diagnostics and PathoNext offer local MammaPrint and BluePrint testing for breast cancer patients in Germany

IRVINE, California, Oct. 6, 2020 /PRNewswire/ -- Agendia Inc., a world leader in precision oncology for breast cancer, announced today the availability of local testing for its CE-marked MammaPrint® BluePrint® Breast Cancer Recurrence and Molecular Subtyping tests, provided by PathoNext lab in Leipzig, Germany. Breast cancer patients in Germany will now have access to state-of-the art genomic profiling in their own country.

Swisscom, Ericsson and Qualcomm join forces to find the world's most innovative 5G applications

ZÜRICH, Sept. 24, 2020 /PRNewswire/ -- Switzerland's leading telecommunications and IT company Swisscom is joining forces with Ericsson and Qualcomm CDMA Technologies GmbH to identify the world's most innovative startups and research teams working on 5G applications. The five winners of theSwisscom StartUp Challengewill be invited to Switzerland in 2021 for an Exploration Week during which they will have the opportunity to carry out extensive testing on their prototypes in Swisscom's live 5G netw...

ora in
Prima pagina
articoli
in Evidenza